Abstract
SACHA-France (NCT04477681) is a prospective real-world study that collects clinical safety and efficacy data of novel anticancer therapies prescribed off-label or on compassionate use to patients <25 years. From March 2020 until February 2024, 640 patients with solid tumors or lymphomas were included, with 176 (28%) reported objective tumor responses. Centralized medical monitoring of local radiological/functional imaging reports by the SACHA coordinating investigator led to response modification in 45 out of 176 cases (26%), highlighting the relevance of the medical review of study data. We suggest this pragmatic approach for improving clinical trial data when centralized radiological review is not performed.
Original language | English |
---|---|
Article number | e31449 |
Journal | Pediatric Blood and Cancer |
Volume | 72 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Feb 2025 |
Keywords
- clinical trials
- oncology
- pediatric oncology
- solid
- tumors